03:19 PM EST - Immunoprecise Antibodies Ltd. : Reported its financial results for the fourth quarter ended April 30, 2017. The Company recorded revenue of $2,630,515 compared to $1,896,118 year ended April 30, 2016. The Company recorded a net loss of $5,383,820 during the year ended April 30, 2017, compared to net income of $151,035 for the year ended April 30, 2016. Immunoprecise Antibodies Ltd.
shares V.IPA are trading unchanged at $1.11.
